Dr. Karlan Discusses AMG 386 in Recurrent Ovarian Cancer

Beth Y. Karlan MD
Published: Thursday, May 05, 2011

Beth Y. Karlan MD, a Director at Cedars-Sinai Women's Cancer Research Institute Discusses AMG 386 in Recurrent Ovarian Cancer
Beth Y. Karlan MD, a Director at Cedars-Sinai Women's Cancer Research Institute Discusses AMG 386 in Recurrent Ovarian Cancer

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Redefining Ovarian Cancer Treatment Paradigms by Maximizing Therapeutic Outcomes with PARP InhibitorsSep 29, 20182.0
Community Practice Connections™: 1st Annual School of Nursing Oncology™Oct 31, 20181.5
Publication Bottom Border
Border Publication
x